University of Maryland | School of Pharmacy Annual
Total Page:16
File Type:pdf, Size:1020Kb
University of Maryland School of Pharmacy. Annual Report 2004-2005 Item Type Annual Report Publication Date 2005 Keywords University of Maryland, Baltimore. School of Pharmacy--Annual Reports Publisher University of Maryland, Baltimore. School of Pharmacy Download date 26/09/2021 23:18:02 Item License https://creativecommons.org/licenses/by-nc-nd/4.0/ Link to Item http://hdl.handle.net/10713/249 focus UNIVERSITY OF MARYLAND | SCHOOL OF PHARMACY ANNUAL REPORT 2004-2005 CONTENTS LEADERSHIP David A. Knapp, PhD Dean William J. Cooper, MBA Associate Dean for Administration and Finance 2 DEAN’S MESSAGE Jill Morgan, PharmD Associate Dean for Student Affairs 3 Magaly Rodriguez de Bittner, PharmD STRATEGIC PLAN Associate Dean for Academic Affairs Angela Wilks, PhD 4 Associate Dean for Research and Graduate Education ACADEMIC PROGRAMS Natalie D. Eddington, PhD DOCTOR OF PHARMACY PROGRAM Chair, Department of Pharmaceutical Sciences PHARMACEUTICAL HEALTH SERVICES RESEARCH GRADUATE PROGRAM Robert J. Michocki, PharmD PHARMACEUTICAL SCIENCES GRADUATE PROGRAM Chair, Department of Pharmacy Practice and Science C. Daniel Mullins, PhD 10 Chair, Department of Pharmaceutical Health Services Research ACADEMIC TRAINING POSTDOCTORAL TRAINING RESIDENCY AND FELLOWSHIP TRAINING CENTERS 14 GRANTS AND AWARDS Center on Drugs and Public Policy Francis B. Palumbo, PhD, JD, Director 21 SCHOOL OF PHARMACY CENTERS Computer-Aided Drug Design Center Alexander D. MacKerell, Jr., PhD, Director 22 Drug Information Center FINANCIALS Rachel A. Bongiorno, PharmD, Director Maryland Poison Center 24 Bruce D. Anderson, PharmD, Director DEVELOPMENT Center for Nanomedicine and Cellular Delivery Hamid Ghandehari, PhD, Director Office of Substance Abuse Studies Anthony C. Tommasello, PhD, Director The Peter Lamy Center on Drug Therapy and Aging Bruce C. Stuart, PhD, Director Pharmaceutical Research Computing Van Doren Hsu, PharmD, Director S C DEAN’S MESSAGE STRATEGIC PLAN H O 2005-2008 O L O F P H A R M A Maryland is a comprehensive School of Pharmacy. By that, I mean it aims to not only C MISSION Y educate excellent pharmacists, but also seek excellence in research, clinical practice, and We enhance health through innovative pharmaceutical 4 service to the profession and society. We cannot, however, do everything. Although we 5 F are among the largest schools of pharmacy in the nation, we are one of the smaller education, research, practice, and public service. Y 0 5 schools on the University of Maryland, Baltimore campus. To achieve excellence within A N VISION 2010 N our comprehensive mission, we must focus on what we want to do. U A We lead the way in advancing the profession of pharmacy. L R • In the PharmD program, we focus on teaching our students how to E P learn and how to choose the best career path from the richness that In our innovative educational, research, and practice settings, students gain the O R the profession offers. knowledge and skill to excel in a variety of pharmaceutical careers. Employing a spirit of T discovery fostered during the course of their studies, our graduates are leaders wherever • In research, we focus on drug discovery, drug development, and they practice, conduct research, or teach. They are essential contributors in the dynamic medication use, seeking to complement the strengths of other health care arena meeting the need for pharmacists within the state of Maryland and campus units. beyond. • In clinical practice, we focus on community practice and on specialty As a top-five research School, we apply an integrative understanding of drug discovery, areas where significant opportunities for collaboration exist. development, and utilization in conducting groundbreaking and translational research. The outcomes from this research make a major impact on improving the quality of • In public service, our focus responds to the needs of our community, people’s lives. our state, and the world around us. We are a formidable influence in shaping drug policy and pharmaceutical practice. The insatiable list of things we might do, coupled with the finite resources we have to Our community service programs bring education and care to people in Baltimore City offer, forces us to focus. Strategic planning provides the mechanism through which we and throughout the state. These endeavors, coupled with our national and international make our choices. collaborations, improve the effectiveness of pharmaceutical care throughout the world. Our faculty, staff, and students create and sustain a welcoming and supportive For better than a year, a special Task Force on the Future of the School of Pharmacy, environment where people develop professionally and use their knowledge and talents composed of members of our faculty and staff, worked to develop our Strategic Plan for to realize this vision. 2005-2008. The plan encompasses a vision for the School that places us in the midst of dynamic changes that are taking place in health care, biomedical research, and health STRATEGIC INITIATIVES professions education. 1 To retain our position as a leader among schools of pharmacy, we will once again Educate the highest caliber pharmacists and pharmaceutical scientists rethink our curriculum, incorporating educational technology to change the ways that we to meet societal needs and market demands. help students learn. In research, we will more fully exploit our contributions to cross- 2 disciplinary, translational, and health services research. And, finally, in order to best prepare Define the future role of pharmacists in health care. our students for the profession of tomorrow, our faculty members will continue to be engaged clinically in the practice of today. 3 Advance the viability and impact of research and scholarship throughout the School. Here then, is the product of our focus in academic year 2005—our Strategic Plan for the years to come. 4 Enhance relationships with external stakeholders. 5 Create a culture of trust, appreciation, and continuous learning within the School. David A. Knapp, PhD Dean S C ACADEMIC PROGRAMS H O O L O F P H A R M A C DOCTOR OF PHARMACY PROGRAM Y The 2004-05 year was rewarding for the School of Pharmacy. U.S.News & World Report 6 7 ranked the School eighth in the nation for the quality of our Doctor of Pharmacy educa- F Y 0 tion, maintaining our ranking as one of the very best schools in the country. This valida- 5 A tion of Maryland’s stature helps us attract top-notch students from throughout the N N U nation. A L R E Despite a shortage of space, the School maintained an increased enrollment to help P O R with the pharmacist shortage in Maryland. From an applicant pool of 1,463, an increase T of 758 over the previous year, 236 had the opportunity to interview, 145 were offered admission, and 120 enrolled. Meet the Incoming Class of 2008 Students Enrolled 120 Mean GPA 3.5 Mean PCAT ( # and percentile) # 221 and 85th % Percent with Baccalaureate 65 Percent Female/Male 65/45 Age Range 19-40 Average Age 25.3 Ethnicity Native American 1 % African-American 15 % Asian 26 % Hispanic 4 % Caucasian 52 % L International 3 % The STUDENT GOVERNMENT ASSOCIATION had many accomplish- ments during the 2004-05 year. They were successful in arranging 42 students to meet with legislators, helped organize the School’s participation in the UMB Health Care Showcase in Annapolis during the 2005 legislative session, established online elections, devel- cation • du pr oped an interactive suggestion box, and instituted a new tradition: e o • f The Spring Formal. y e t i s l s a i o u n q focus a L • l i e JILL MORGAN, PharmD, was named associate dean for student affairs s c m n on June 1, 2005. She succeeded Robert Beardsley, RPh, PhD, who e • i l c e s stepped down after 17 years of dedicated service to resume his full- a • d p e i r h s time faculty position in the Department of Pharmaceutical Health Services Research. S C H O O L O F P H A R M A Pharmaceutical Health Services Research Graduate Program C Y With the widespread use of medications in society, the demand for individuals skilled 8 9 in the evaluation of pharmaceutical services and interventions has increased. To help F Y meet this growing demand, the Pharmaceutical Health Services Research graduate 0 5 A program continued to train strong researchers during the 2004-05 year in a variety of N N important areas. U A L R Currently, 26 students are enrolled in the program. During their course of study, they E P O are provided with theory, practical experience, and the decision-making skills needed to R T address a wide range of pharmacy-related problems. Some areas of academic and research interest include the role of the federal and state governments in health care policy, third-party programs, drug utilization, cost contain- ment, medication compliance, provision of pharmaceutical services, role of health practitioners, and diffusion of new technologies into the medical care setting. Meet the Students Who Enrolled in 2004 Students Enrolled 4 Mean GPA 3.75 Percent Female/Male 50/50 Ethnicity African-American, Non Hispanic 1 International, Asian 3 FOCUS ON RESEARCH JOSE JOSUE HERNANDEZ, a PhD candidate, received the University of Maryland, Baltimore, Graduate School Enrichment Fellowship for the academic years 2004-05 and 2005-06, and completed an internship at Pfizer Global Epidemiology in Barcelona, Spain, in spring 2005. His research focus area is pharmacoepidemiology of aging. His dissertation research is, “Disparities in Optimal Prescribing Between Medicare Long-Term Care Elderly Residents With and Without Dementia.” s • me re “I decided to attend the University of Maryland Department of Pharmaceutical o s c e Health Services Research because of the diverse research opportunities within the t a department, and its reputation,” says Hernandez.